<SUBMISSION>
<ACCESSION-NUMBER>0000943440-04-000590
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20041025
<ITEMS>7.01
<ITEMS>9.01
<FILING-DATE>20041027
<DATE-OF-FILING-DATE-CHANGE>20041027
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>PETMED EXPRESS INC
<CIK>0001040130
<ASSIGNED-SIC>5912
<IRS-NUMBER>650680967
<STATE-OF-INCORPORATION>FL
<FISCAL-YEAR-END>0330
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-28827
<FILM-NUMBER>041098977
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1441 SW 29 AVENUE
<CITY>POMPANO BEACH
<STATE>FL
<ZIP>33069
<PHONE>9549794788
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1441 SW 29 AVENUE
<CITY>POMPANO BEACH
<STATE>FL
<ZIP>33069
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>oct25-8k.txt
<TEXT>
==========================================================================


                               UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549
                                 __________

                                  FORM 8-K

                                CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported): October 25, 2004


                           PETMED EXPRESS, INC.
            ----------------------------------------------------
           (Exact name of registrant as specified in its charter)

                Commission file number 000-28827
                                       ---------

         FLORIDA                              65-0680967
 ------------------------------           -------------------
  (State or other jurisdiction               (IRS Employer
of incorporation or organization)         Identification No.)


1441 S.W. 29th Avenue, Pompano Beach, Florida        33069
---------------------------------------------      ----------
  (Address of principal executive offices)         (Zip Code)

 Registrant's telephone number, including area code: (954) 979-5995
                                                     --------------
                      Not Applicable
    -----------------------------------------------------------
   (Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

[   ] Written communications pursuant to Rule 425 under the Securities Act

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[   ] Pre-commencement communications pursuant to Rule 14d-2(b)
      under the Exchange Act

[   ] Pre-commencement communications pursuant to Rule 13e-4(c)
      under the Exchange Act



<PAGE>



Item 7.01   Regulation FD Disclosure

     On October 25, 2004, PetMed Express, Inc. issued a press
release announcing its September 30, 2004 quarter end financial
results.  A copy of this news release is attached hereto as
Exhibit 99.1 and is incorporated herein by reference.

     The information furnished in this Item 9, intended to be
furnished under Item 12, is instead furnished under Item 9 in
accordance with SEC Release 33-8216.  This information shall not
be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") nor shall
such information be incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act,
except as shall be expressly set forth by specific reference in
such filing.

Item 9.01   Financial Statements and Exhibits

     (c)  Exhibits

99.1 Press Release issued by PetMed Express, Inc. on October 25, 2004



<PAGE>



                                 SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


PETMED EXPRESS, INC.
(The "Registrant")

Date: October 27, 2004

By:  /s/  Menderes Akdag
     ------------------------
     Menderes Akdag

     Chief Executive Officer
     (principal executive officer)

By:  /s/  Bruce S. Rosenbloom
     --------------------------------
     Bruce S. Rosenbloom

     Chief Financial Officer
     (principal financial and accounting officer)



 <PAGE>



                               EXHIBIT INDEX

Exhibit No.                      Description


99.1        Press Release issued by PetMed Express on October 25, 2004



<PAGE>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>oct258k-ex991.txt
<TEXT>

                                EXHIBIT 99.1

Date:     October 25, 2004
Contact:  Bruce S. Rosenbloom, CFO
Phone:    (954) 979-5995
Fax:      (954) 971-0544

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES SECOND QUARTER
FINANCIAL RESULTS

Pompano Beach, Florida, October 25, 2004 - PetMed Express, Inc.
(NASDAQ: PETS) today announced results for the quarter ended
September 30, 2004.  Net sales for the three months ended
September 30, 2004 were $28.8 million, compared to $25.0 million
for the three months ended September 30, 2003, an increase of
15%.  Net income was $1.8 million, or $.08 diluted per share, in
each of the quarters ended September 30, 2004 and 2003.  Net
sales for the six months ended September 30, 2004 were $64.0
million, compared to $55.4 million for the six months ended
September 30, 2003, an increase of 16%.  Net income was $3.6
million, or $.15 diluted per share, for the six month period,
compared to net income of $3.3 million or $.14 diluted per share,
for the same period a year ago, an increase of 12%.

Mendo Akdag, CEO, commented: "Our reorder sales increased 34%,
from $12.9 million to $17.2 million for the three months ended
September 30, 2003 and 2004, and our reorder sales increased 46%,
from $25.4 million to $37.2 million for the six months ended
September 30, 2003 and 2004, respectively.  We also acquired
approximately 154,000 new customers in the quarter and
approximately 345,000 new customers for the six month period, and
approximately 52% of all orders were placed on our website for
the quarter."

Founded in 1996, PetMed Express is America's largest pet
pharmacy, delivering prescription and non-prescription pet
medications and health and nutritional supplements for dogs and
cats at competitive prices direct to the consumer through its 1-
800-PetMeds toll free number and on the Internet through its
website at www.1800PetMeds.com.

This press release may contain "forward-looking" statements, as
defined in the Private Securities Litigation Reform Act of 1995
or by the Securities and Exchange Commission, that involve a
number of risks and uncertainties, including the Company's
ability to meet the objectives included in its business plan.
Important factors that could cause results to differ materially
from those indicated by such "forward-looking" statements are set
forth in Management's Discussion and Analysis of Financial
Condition and Results of Operations in the PetMed Express Annual
Report on Form 10-K for the year ended March 31, 2004.  The
Company's future results may also be impacted by other risk
factors listed from time to time in its SEC filings, including,
but not limited to, the Company's Form 10-Q and its Annual Report
on Form 10-K.

For investment relations contact PetMed Express, Inc., Pompano
Beach, Bruce S. Rosenbloom, CFO, 954-979-5995.



                                ###

                         99.1 page 1 - 2


<PAGE>



                    PETMED EXPRESS, INC. AND SUBSIDIARIES
                            FINANCIAL HIGHLIGHTS

                 CONDENSED CONSOLIDATED STATEMENT OF INCOME
                                (UNAUDITIED)

<TABLE>
<CAPTION>

                                                     Three Months Ended             Six Months Ended
                                                        September 30,                 September 30,
                                                  2004                2003        2004             2003
                                             ------------    ------------    ------------     ------------
<S>                                         <C>             <C>             <C>              <C>

Sales                                       $  28,754,697   $  24,969,228   $  64,043,225    $  55,356,791
Cost of sales                                  17,141,556      14,745,824      38,568,275       33,328,504
                                             ------------    ------------    ------------     ------------

Gross profit                                   11,613,141      10,223,404      25,474,950       22,028,287
                                             ------------    ------------    ------------     ------------
Operating expenses:

General and administrative                      2,971,268       2,718,371       6,193,173        5,739,625
  Advertising                                   5,629,991       4,443,980      13,384,820       10,952,970
  Depreciation and amortization                   155,294         132,049         314,353          259,400
                                             ------------    ------------    ------------     ------------
Total operating expenses                        8,756,553       7,294,400      19,892,346       16,951,995
                                             ------------    ------------    ------------     ------------

Income from operations                          2,856,588       2,929,004       5,582,604        5,076,292

Other income (expense)
  Interest expense                                   (138)         (1,526)           (880)          (4,207)
  Interest income                                  17,372           4,705          22,005            6,854
  Other, net                                        1,821             378           1,411              986
                                             ------------    ------------    ------------     ------------
Total other income (expense)                       19,055           3,557          22,536            3,633
                                             ------------    ------------    ------------     ------------

Income before provision for income taxes        2,875,643       2,932,561       5,605,140        5,079,925

Provision for income taxes                      1,063,988       1,114,373       1,975,347        1,829,153
                                             ------------    ------------    ------------     ------------

Net income                                  $   1,811,655   $   1,818,188   $   3,629,793    $   3,250,772
                                             ------------    ------------    ------------     ------------
Net income per common share:
  Basic                                     $        0.08   $        0.09   $        0.16    $        0.17
                                             ============    ============    ============     ============
  Dilutive                                  $        0.08   $        0.08   $        0.15    $        0.14
                                             ============    ============    ============     ============
Weighted average number of
  common shares outstanding:
  Basic                                        22,719,266      19,372,365     22,370,162        19,192,390
                                             ============    ============    ============     ============
  Dilutive                                     23,860,513      23,425,269     23,463,939        23,103,919
                                             ============    ============    ============     ============

                                                 BALANCE SHEET DATA
                                             September 30,     March 31,
                                                2004             2004
                                             (Unaudited)
                                              -----------     -----------

Working capital                             $  16,963,569   $  11,338,004
Total assets                                   23,740,590      18,480,808
Total liabilities                               4,331,941       4,486,299
Total shareholders' equity                     19,408,649      13,994,509

</TABLE>


                         99.1 page 2 - 2


<PAGE>





</TEXT>
</DOCUMENT>
</SUBMISSION>
